Sol-Gel Technologies Ltd’s $23 Million Follow-on Offering

Gornitzky represented the underwriters, led by Jefferies and BMO Capital Markets, in Sol-Gel Technologies Ltd.’s USD 23 million follow-on offering of shares and warrants on the Nasdaq Global Market.

Sol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.

Jefferies and BMO Capital Markets acted as joint book-running managers for the offering, Raymond James & Associates acted as lead manager for the offering and H.C. Wainwright acted as co-manager for the offering.

The Gornitzky team was led by partners Chaim Friedland (Picture) and Ari Fried, and also included associates Neta Peled and Sharon Reingwirtz.

Involved fees earner: Ari Fried – Gornitzky & Co.; Chaim Friedland – Gornitzky & Co.; Neta Peled – Gornitzky & Co.;

Law Firms: Gornitzky & Co.;

Clients: BMO Capital Markets; H.C. Wainwright & Co.; Jefferies Finance LLC; Raymond James & Associates, Inc.;

Author: Michael Patrini.